" class="no-js "lang="en-US"> David Jenkins Discussing Antimicrobial Chemotherapy
Thursday, June 08, 2023

David Jenkins, University Hospitals of Leicester, Discussing Antimicrobial Chemotherapy

In the video, David Jenkins, a consultant medical microbiologist from the University Hospitals of Leicester, discusses the issue of antibiotic resistance and the need for the development of new antibiotics. He also highlights the importance of organisations such as the British Society for Antimicrobial Chemotherapy (BSAC) in tackling this unmet need.

Jenkins also discusses how BSAC provides education to members through meetings and online webinars, as well as publishing leading journals.

Overall, Jenkins stresses the urgent need for action to address the growing problem of antibiotic resistance and calls for a collaborative effort between healthcare professionals, researchers, and policymakers to ensure the continued availability of effective antibiotics for the treatment of infectious diseases across not just the UK, but the world.

  1. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Read more
  2. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease Read more
  3. MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator Read more
  4. XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Read more
  5. Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Read more